• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Why Niacinamide Outshines Resveratrol

niacinamide resveratrol nad+ sirt1

  • Please log in to reply
No replies to this topic

#1 osris

  • Guest
  • 531 posts
  • 81 â‚®

Posted 23 March 2024 - 04:13 PM


WHY NIACINAMIDE OUTSHINES RESVERATROL

 

by 

 

ChatGPT

 

 

In the quest for longevity and optimal health, the pursuit of supplements capable of activating SIRT1, a key player in cellular maintenance and anti-aging processes, has been fervent. Among the contenders, two compounds have emerged as potential candidates: resveratrol and niacinamide. While both have been touted for their SIRT1 activation capabilities, the evidence overwhelmingly supports niacinamide as the superior choice for NAD+ activation and maintenance. This should not suggest that nicotinamide is inferior to resveratrol for SIRT1 activation. It simply highlights that while both compounds have been promoted for their ability to activate SIRT1, the evidence strongly favors nicotinamide as the better choice for activating and maintaining NAD+ levels, which are crucial for SIRT1 function. 

 

The Niacinamide Advantage: Direct Pathway to NAD+

 

Niacinamide, also known as nicotinamide or vitamin B3, operates at the very heart of the NAD+ metabolic pathway. It serves as a direct precursor to NAD+, the coenzyme essential for SIRT1 function. Unlike resveratrol, which acts primarily on SIRT1, niacinamide ensures a steady supply of NAD+ by bolstering its biosynthesis pathways. By providing the building blocks necessary for NAD+ synthesis, niacinamide ensures sustained cellular levels of this critical coenzyme, facilitating optimal SIRT1 activity.

 

Safeguarding Cellular Integrity: Niacinamide's PARP Inhibition

 

Moreover, niacinamide's impact on NAD+ levels extends beyond mere provision. It serves as a potent inhibitor of the NAD+-consuming enzyme, poly(ADP-ribose) polymerase (PARP). PARP enzymes are notorious for their voracious consumption of NAD+ during DNA repair processes, leading to NAD+ depletion and compromised cellular function. Niacinamide's ability to inhibit PARP activity safeguards NAD+ reserves, preserving cellular integrity and resilience.

 

Resveratrol's Indirect Approach: NAD+ Boost vs. Niacinamide

 

In stark contrast, resveratrol's mechanisms of action are less direct and efficient in NAD+ maintenance. While resveratrol's activation of SIRT1 is well-documented, its impact on NAD+ levels is largely indirect. Resveratrol may enhance NAD+ synthesis pathways by upregulating enzymes like NAMPT, but its efficacy in sustaining NAD+ levels falls short compared to niacinamide. Furthermore, resveratrol's effects on NAD+ may be overshadowed by its numerous other physiological effects, diluting its potency as a dedicated NAD+ booster.

 

Compelling Evidence: Niacinamide's Efficacy in NAD+ Maintenance

 

The evidence supporting niacinamide's superiority over resveratrol in NAD+ maintenance is compelling. Numerous studies have demonstrated niacinamide's ability to elevate NAD+ levels in various cell types and animal models, showcasing its robust and consistent efficacy. In contrast, resveratrol's impact on NAD+ levels appears less pronounced and more variable across studies, raising doubts about its reliability as a primary NAD+ modulator.

 

Safety Profiles: Niacinamide vs. Resveratrol

 

Furthermore, the safety profile of niacinamide far surpasses that of resveratrol. Niacinamide is a well-tolerated vitamin supplement widely used in clinical settings for conditions like niacin deficiency and dermatological disorders. In contrast, resveratrol's long-term safety and efficacy remain subjects of ongoing debate, with concerns raised about its potential adverse effects and interactions with other medications.

 

Addressing Concerns: Niacinamide's Effect on SIRT1 Activity

 

Some have voiced concerns over niacinamide's potential to inhibit SIRT1 activity. While it is true that high concentrations of niacinamide can competitively inhibit SIRT1, the physiological relevance of this inhibition is often overplayed.  Studies indicate that niacinamide's ability to inhibit SIRT1 becomes notable only at high  supplement dosages. At typical supplement dosages of niacinamide, which range from 250 mg to 1000 mg per day, the inhibitory effects on SIRT1 are negligible.

 

However, in many studies, it is not entirely clear whether niacinamide actually inhibits sirtuins. For instance, in one study, treating mice with niacinamide made sirtuin proteins less active after 6 or 12 hours, but this effect was not seen after 24 hours. It seems that when animals or cells are given niacinamide, the sirtuin proteins are inhibited for a short time but then become more active afterwards. This is because niacinamide levels go up quickly after treatment but then go back down after a while.

 

Similarly, levels of NAD+ also go up after niacinamide treatment and stay high for a while. So, even though niacinamide might briefly inhibit sirtuins, they become more active again once niacinamide levels drop and NAD+ levels increase.

 

Conclusion

 

In conclusion, niacinamide emerges as the clear frontrunner in the race for optimal NAD+ activation and maintenance. Its direct role in NAD+ synthesis, coupled with its ability to inhibit NAD+-consuming enzymes, positions it as the ideal choice for those seeking to harness the power of SIRT1 and promote cellular health. While resveratrol may have its merits, niacinamide's efficacy, safety, and direct impact on NAD+ levels make it the undisputed champion in the battle against aging and degenerative disease.


Edited by osris, 23 March 2024 - 04:30 PM.

  • unsure x 1





Also tagged with one or more of these keywords: niacinamide, resveratrol, nad+, sirt1

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users